Completed
A Study of Tucidinostat Combined With Tislelizumab as First-line Treatment in Advanced NSCLC
NCT05519865
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Shanghai Pulmonary Hospital Shanghai, Shanghai Municipality, China